Spasimir T. Shopov‡, Benyamin L. Anavi§, Dobrin K. Krastev|Corresponding author: Spasimir T. Shopov ( sshopov1@abv.bg ) © Spasimir T. Shopov, Benyamin L. Anavi, Dobrin K. Krastev. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Citation:
Shopov ST, Anavi BL, Krastev DK (2020) Large-cell Neuroendocrine Carcinoma of the Endometrium in Myomatous Uterus. Folia Medica 62(2): 412-417. https://doi.org/10.3897/folmed.62.e49815 |  |
Large-cell neuroendocrine carcinoma of the endometrium is an insufficiently researched aggressive tumor with a short survival regardless of the treatment type.
We present here the 38th consecutive case of literature reported cases of large cell neuroendocrine carcinoma of the endometrium (positive for synaptophysin, CD56, chromogranin A, p53, and Vimentin) found in the myomatous uterus of a 76-year-old woman.
We also describe in the study the morphological algorithm for differentiation of malignant blastomas with small (under 10 %) neuro-endocrinal component.
Accumulated clinical and morphological evidence raises the question whether the large-cell and the small-cell neuroendocrine carcinomas are just different variations according to their histology and topical occurrence (uterine body/cervix) or they are just independent forms with their respective clinical signs, morphology, treatment, and prognosis.